Prism Medico And Pharmacy Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve With reference to ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The company has scheduled a board meeting on 28 May 2026 at 3:00 PM at their registered office in Sirmaur, Himachal Pradesh. The primary agenda is to consider and approve the Audited Standalone Financial Results for Q4 and the financial year ended 31 March 2026, along with the Auditor's Report. The meeting is being held under SEBI LODR Regulation 29(1) disclosure requirements. Any other routine business matters may also be discussed.
This meeting announcement signals that Q4 FY2026 and full-year audited financial results are expected to be approved and released shortly, which could impact the stock price once disclosed. Investors should watch for the subsequent results announcement.